摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N,N,N',N'-tetramethyl-7,8-dihydro-6H-dipyrido[1,2-a;2',1'-c][1,4]diazepine-2,12-diamine | 1011717-60-4

中文名称
——
中文别名
——
英文名称
N,N,N',N'-tetramethyl-7,8-dihydro-6H-dipyrido[1,2-a;2',1'-c][1,4]diazepine-2,12-diamine
英文别名
7,8-Dihydro-n2,n2,n12,n12-tetramethyl-6h-dipyrido[1,2-a:2',1'-c][1,4]diazepine-2,12-diamine;4-N,4-N,14-N,14-N-tetramethyl-7,11-diazatricyclo[9.4.0.02,7]pentadeca-1,3,5,12,14-pentaene-4,14-diamine
N,N,N',N'-tetramethyl-7,8-dihydro-6H-dipyrido[1,2-a;2',1'-c][1,4]diazepine-2,12-diamine化学式
CAS
1011717-60-4
化学式
C17H24N4
mdl
——
分子量
284.404
InChiKey
YCMAQGUYIMVCFM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    350.1±42.0 °C(Predicted)
  • 密度:
    1.16±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    21
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.41
  • 拓扑面积:
    13
  • 氢给体数:
    0
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    N,N,N',N'-tetramethyl-7,8-dihydro-6H-dipyrido[1,2-a;2',1'-c][1,4]diazepine-2,12-diamine 作用下, 以 乙醚 为溶剂, 反应 0.5h, 以99%的产率得到N,N,N',N'-tetramethyl-7,8-dihydro-6H-dipyrido[1,2-a:2',1'-c][1,4]-diazepine-5,9-diium-2,12-diamine diiodide
    参考文献:
    名称:
    衍生自 4-二甲氨基吡啶的中性有机电子供体的结构和反应性。
    摘要:
    通过改变两个参数,已经探索了对衍生自 4-二甲氨基吡啶 (4-DMAP) 的中性双-2-(4-二甲氨基) 亚吡啶电子供体的分子骨架进行修饰对氧化还原性能的影响:(i)连接两个吡啶衍生环的多亚甲基链的长度和 (ii) 前体吡啶的 4 和 4' 位置上的氮取代基的性质。将桥长度限制为两个亚甲基单元显着改变了氧化还原曲线,而 4 和 4' 位置的氮取代基的变化仅导致氧化还原电位的轻微变化。
    DOI:
    10.3762/bjoc.6.73
  • 作为产物:
    描述:
    1,1'-(propane-1,3-diyl)-bis(4-(dimethylamino)pyridin-1-ium) dibromide 在 、 sodium hydride 作用下, 反应 4.0h, 以89%的产率得到N,N,N',N'-tetramethyl-7,8-dihydro-6H-dipyrido[1,2-a;2',1'-c][1,4]diazepine-2,12-diamine
    参考文献:
    名称:
    通过中性有机供体的光活化电子转移对 C?N 和 S?N 键进行无金属还原裂解
    摘要:
    光活化的中性有机超电子供体在室温下裂解衍生自二烷基胺的具有挑战性的芳烃磺酰胺。它还裂解 a) ArC  NR 和 b) ArN  C 键。该研究还强调了通过降低 LUMO 能量和稳定碎裂产物,连接到 (a) 中的 N 和连接到 (b) 中的 C 的基团对这些裂解反应的帮助。
    DOI:
    10.1002/anie.201306543
  • 作为试剂:
    参考文献:
    名称:
    光活化的中性有机电子给体分子将电子转移到苯上
    摘要:
    强大的还原反应:仅由碳,氢和氮元素组成的简单有机电子给体,通过光活化后的电子转移将基态苯环还原为自由基阴离子(DMF =二甲基甲酰胺)。
    DOI:
    10.1002/anie.201200084
点击查看最新优质反应信息

文献信息

  • Metal-free reduction of the greenhouse gas sulfur hexafluoride, formation of SF<sub>5</sub>containing ion pairs and the application in fluorinations
    作者:Magnus Rueping、Pavlo Nikolaienko、Yury Lebedev、Alina Adams
    DOI:10.1039/c7gc00877e
    日期:——
    A protocol for the fast and selective two-electron reduction of the potent greenhouse gas sulfur hexafluoride (SF6) by organic electron donors at ambient temperature has been developed. The reaction yields solid ion pairs consisting of donor dications and SF5-anions which can be effectively used in fluorination reactions.
    已经开发了一种在环境温度下通过有机电子给体快速有效地二价还原强效温室气体六氟化硫(SF 6)的方案。该反应产生由供体离子和SF 5-阴离子组成的固体离子对,可以有效地用于化反应中。
  • ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES
    申请人:UNIVERSAL DISPLAY CORPORATION
    公开号:US20190051845A1
    公开(公告)日:2019-02-14
    A compound having a structure of the formula Ir(L A )(L B ), in which L A is a bidentate, tridentate, tetradentate, pentadentate, or hexadentate ligand and L B is a monodentate, bidentate, tridentate, or tetradentate ligand, or not present, and where the total denticity of L A plus L B is 6, and L A includes at least one structure of Formula I: is disclosed as a useful phosphorescent emitter compound.
    一种具有Ir(LA)(LB)分子结构的化合物被披露为一种有用的光发射剂,其中LA是双齿、三齿、四齿、五齿或六齿配体,LB是单齿、双齿、三齿或四齿配体,或者不存在,LA和LB的总配位数为6,LA至少包括一个I式结构。
  • Super electron donor-mediated reductive desulfurization reactions
    作者:Kanako Nozawa-Kumada、Shungo Ito、Koto Noguchi、Masanori Shigeno、Yoshinori Kondo
    DOI:10.1039/c9cc06775b
    日期:——
    The desulfurization of thioacetals and thioethers by a pyridine-derived electron donor is described. This methodology provides efficient access to the reduced products in high yields and does not require the use of transition-metals, elemental alkali-metals, or hydrogen atom donors.
    描述了通过吡啶衍生的电子供体对缩醛醚的脱。这种方法可以高效地获得高产率的还原产物,并且不需要使用过渡属,元素碱属或氢原子供体。
  • Organic Electroluminescent Materials and Devices
    申请人:Universal Display Corporation
    公开号:US20200274081A1
    公开(公告)日:2020-08-27
    A compound of Formula I wherein: ring B is a 5-membered heterocyclic ring, or a 6-membered carbocyclic ring; each of X 1 and X 2 is independently C, CR, or N, with at least one of them being C; each of X 3 -X 11 is independently C, CR, or N, with at least one of them being N, and two adjacent of X 3 -X 7 are carbon-fused to the shown moiety through the linkage indicated by the two squiggly lines; Y is selected from the group consisting of O, S, Se, NR′, CR′R″, and SiR′R″; each of R A and R B independently represents zero, mono, or up to a maximum allowed substitution to its associated ring; each of R, R′, R″, R A , and R B is independently a hydrogen or a substituent selected from the group consisting of —SiR 1 R 2 R 3 or —GeR 1 R 2 R 3 , deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, with at least one of R A or R B comprising —SiR 1 R 2 R 3 or —GeR 1 R 2 R 3 ; each of R 1 , R 2 , and R 3 is independently selected from the group consisting of alkyl, aryl group, heteroaryl group, and combinations thereof; and any two substituents are optionally joined or fused to form a ring where chemically feasible.
    根据公式I的化合物 其中: 环B是5元的杂环,或者是6元的碳环; X1和X2各自独立为C、CR或N,其中至少有一个是C; X3-X11各自独立为C、CR或N,其中至少有一个是N,并且X3-X7的两个相邻碳与所示基团通过波浪线指示的连接方式碳融合; Y选自由O、S、Se、NR'、CR'R"和SiR'R"组成的组; RA和RB各自独立代表其相关环允许的最大取代数,零、单或至多; R、R'、R"、RA和RB各自独立为氢或选自—SiR1R2R3或—GeR1R2R3,,卤素,烷基,环烷基,杂烷基,杂环烷基,芳烷基,烷氧基,芳氧基,基,基,基,烯基,环烯基,杂烯基,炔基,芳基,杂芳基,酰基,羧酸,醚,酯,腈,异腈,anyl,亚磺酰基,磺酰基,基和它们的组合的取代基,其中至少一个RA或RB包含—SiR1R2R3或—GeR1R2R3; R1、R2和R3各自独立选自烷基,芳基组,杂芳基组和它们的组合;并且 任意两个取代基可选择性连接或融合成环,在化学上可行的话。
  • Metal-Free Reductive Cleavage of C−O σ-bonds in Acyloin Derivatives by an Organic Neutral Super-Electron-Donor
    作者:Sylvain P. Y. Cutulic、Neil J. Findlay、Sheng-Ze Zhou、Ewan J. T. Chrystal、John A. Murphy
    DOI:10.1021/jo901815t
    日期:2009.11.20
    Neutral organic electron-donor 7, formally a pyridinylidene carbene dimer, effects reductive cleavage of C−O σ-bonds in acyloin derivatives Ar(CO)CRR′OX (X = OAc, OPiv, OBz, OMs) and this represents the first cleavage of C−O σ-bonds by a neutral organic electron-donor. The methodology is applicable to a large array of substrates and the reduced counterparts were isolated in good to excellent yields
    中性有机电子给体7(通常为吡啶基亚苄基卡宾二聚体)实现酰生物Ar(CO)CRR'OX(X = OAc,OPiv,OBz,OMs)中CO键的还原裂解,这是首次裂解中性有机电子给体对C-Oσ键的影响。该方法学适用于大量的底物,并且还原的对应物以良好至极好的产率被分离出来。对于某些底物,供体7起碱的作用,与酰基辅酶的一些乙酸酯衍生物进行缩合反应,生成丁烯内酯。不同底物之间反应性的变化是合理的。
查看更多

同类化合物

雷唑巴占 唑美巴占 六氢-2-(硝基亚氨基)-1H-1,3-二氮杂卓 [1,3]恶唑并[3,2-a][1,3]二氮杂卓 7-苯基-3,4-二氢-1H-1,4-二氮杂革-5(2H)-酮 7,8-二氢-1-苯基-6H-吡啶并(3,2,1-jk)(1,4)苯并二氮杂卓-4(3H)-酮 5H-吡咯并[1,2-a][1,4]二氮杂卓 5-甲基-7-苯基-6,7-二氢-1H-1,4-二氮杂-2,3-二甲腈 5-三氟甲基-2,3-二氢-1H-1,4-二氮杂卓 5,7-二苯基-2,3,6,7-四氢-1H-1,4-二氮杂卓 5,7-二甲基-2,3-二氢-1H-[1,4]二氮杂卓高氯酸盐 5,7-二甲基-2,3,5,6-四氢-1H-环戊二烯并[b]吡嗪 4,5,6,7-四氢-1H-1,3-二氮杂卓-2-胺 3,5,7-三苯基-4H-1,2-二氮杂卓 2H-[1,3,5]恶二嗪o[3,2-a][1,3]二氮杂卓 2-甲基硫代-4,5,6,7-四氢-1H-[1,3]二氮杂卓 2-甲基-4,5,6,7-四氢-1H-1,3-二氮杂卓 2,3-二氢-5-甲基-7-三氟甲基-1H-1,4-二氮杂卓 2,3-二氢-5,7-双(三氟甲基)-1H-1,4-二氮杂卓 1-(5-甲氧基-1,4-二氮杂-1-基)乙酮 1,4,5,7,8,9,10,10A-八氢吡啶并[1,2-a][1,4]二氮杂卓 (9ci)-2,3-二氢-N,N-二甲基-1H-1,4-二氮杂卓-6-甲胺 (9ci)-1H-1,2-二氮杂卓-1-羧酸甲酯 (9ci)-1H,3h-噁唑并[3,4-d][1,4]二氮杂卓 (9ci)-1H,3h-噁唑并[3,4-a][1,4]二氮杂卓 8-Phenyl-2,3,6,7-tetrahydro-4H-1,4-diazocin-5-on 1,3-diphenyl-1,2-dihydro-pyridazino[3,4-b]quinoxaline 3-(4-Bromphenyl)-5,6,7,8-tetrahydro-thiazolo<3,2-a>-<1,3>diazepin 2,3-Dihydro-5-methyl-1,4-diazepin 3-Methyl-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a][1,3]diazepine 2,4,10,12,18,20-hexamethyl-1,5,9,13,17,21-hexaaza-cyclotetracosa-1,3,9,11,17,19-hexaene 2-(2-benzylidene-3-((4-methylbenzylidene)hydrazineylidene)-2,3,6,7,8,9-hexahydro-5H-thiazolo[2,3-b]quinazolin-5-yl)phenol 3,11-diphenyl-1,5,9,13-tetraaza-cyclohexadeca-1,3,9,11-tetraene 7,10-dichloro-4-[4-(1,1-difluoroethyl)phenyl]-5,6-dihydro-4H-pyrrolo[1,2-a][1,4]-benzodiazepine hydrochloride 7-bromo-5,6-dihydro-2,3-dimethylpyrido<2,3-b>pyrazine 7-(3-Chloro-4-fluoro-phenyl)-5-trifluoromethyl-2,3-dihydro-1H-[1,4]diazepine 6,14-diphenyl-1,4,8,12-tetraaza-cyclopentadeca-4,6,12,14-tetraene 6,13-diphenyl-1,4,8,11-tetraaza-cyclotetradeca-4,6,11,13-tetraene 7-(3-Chloro-4-fluoro-phenyl)-5-phenyl-2,3-dihydro-1H-[1,4]diazepine 7-(4-Fluoro-phenyl)-5-methyl-2,3-dihydro-1H-[1,4]diazepine 3-(7-methyl-5-oxo-4,5-dihydro-2H-pyrazolo[1,5-a]pyrimidin-1-yl)-but-2-enenitrile 7-(2-Fluoro-5-methyl-phenyl)-5-methyl-2,3-dihydro-1H-[1,4]diazepine trans-diazido(2,3,9,10-tetramethyl-1,4,8,11-tetra-azacyclotetradeca-1,3,8,10-tetraene)cobalt(III) perchlorate 2,2-dimethyl-2,6,7,8-tetrahydro-3H-pyrrolo[1,2-a]pyrimidin-4-one ethyl 4-acetamidodiazepine-1-carboxylate 5,7-dimethyl-4,5,6,7-tetrahydro-1H-[1,4]diazepine-2,3-dicarbonitrile 1,4,8,11-Tetraazacyclotetradeca-4,6,11,13-tetraene,5,7,12,14-tetramethyl- 5,6,6,7a-tetramethyl-3-phenyl-5,6,7,7a-tetrahydro-pyrazolo[1,5-d][1,2,4]oxadiazole